Article

On science: McCain v. the GOP

When it comes to matters of science, Republican US presidential hopeful John McCain is with his party on some issues, not quite on others. This week the Republican Party released linkurl:a draft of;http://www2.nationalreview.com/dest/2008/08/25/fulldraftaug25.pdf its 2008 platform, one that will be debated in the days leading up to the GOP convention in St Paul, Minnesota, starting Monday (September 1). Some of the party's points regarding science differ from the campaign points McCain has be

Written byAndrea Gawrylewski
| 2 min read
Save for Later
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
When it comes to matters of science, Republican US presidential hopeful John McCain is with his party on some issues, not quite on others. This week the Republican Party released linkurl:a draft of;http://www2.nationalreview.com/dest/2008/08/25/fulldraftaug25.pdf its 2008 platform, one that will be debated in the days leading up to the GOP convention in St Paul, Minnesota, starting Monday (September 1). Some of the party's points regarding science differ from the campaign points McCain has been running on for more than a year. While McCain and his party agree that federal dollars should be spent on supporting biomedical research, the rub is certainly linkurl:embryonic stem cell research.;http://www.the-scientist.com/blog/display/54544/ McCain openly supports work with embryonic stem cells, whereas the party platform calls for an expansion of stem cell research, with a focus on sources such as umbilical cord blood and linkurl:reprogrammed pluripotent;http://www.the-scientist.com/blog/display/54918/ (iPS) cells. Both oppose human cloning and the creation of human embryos for research purposes. Another major difference is how McCain has proposed to confront linkurl:global warming.;http://www.the-scientist.com/article/display/54049/ The party's stance is that technological developments and market-based solutions will lead to lower emissions; they oppose government regulations and would offer cash prizes for innovation. McCain on the other hand has outlined a cap and trade system to be applied to commercial and industrial businesses. Under this plan entities would be able to buy and sell rights to emit, with limits on total emissions. Despite the differences in stance, McCain's aides linkurl:told Bloomberg News;;http://www.bloomberg.com/apps/news?pid=newsarchive&sid=ahIrsc3U8e9E that they don't plan to fight the party over platform positions. Official party platforms are not binding, and candidates are not required to adhere to them, but rather form their own policies. For a peek at some of the science advocates who may be whispering in the ear of the next president, stay tuned for a feature appearing in the September issue of The Scientist.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Join for free today
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Share

Related Research Resources

A menstrual cup and storage bag on a blue background

Collecting Insights into the Vaginal Microbiome and Menstrual Health

Article

DNA Genotek logo
An illustration of PFAS in the bloodstream.

Uncovering the Harmful Effects of PFAS Exposure on the Human Body

Infographic

An illustration of PFAS bubbles in front of a blue sky with clouds.

PFAS: The Forever Chemicals

Infographic

sartorius logo
Abstract paint splashes resembling viral particles on a colorful background.

Accelerating Pathogen Detection with Nanopore Sequencing

Whitepaper

Oxford Nanopore Technologies Logo
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Product News

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo